• Mashup Score: 0

    Purpose of Review Surgical treatment of breast cancer is becoming increasingly more minimally invasive. We review the development status of percutaneous management for primary breast cancer and the evidence relating to tumor size as a fundamental determinant of treatment clinical outcome. Recent Findings It is safe and feasible for percutaneous management to treat breast cancer. For tumor size ≤…

    Tweet Tweets with this article
    • Hot off the press in Current Oncology Reports! Superb systematic review by Dr. Ping Liang's team from Chinese PLA General Hospital on the percutaneous management of #breastcancer! An effective, yet underutilized treatment modality. #irad #ablation https://t.co/2zvtWeID07 https://t.co/OLU6gRUMMf

  • Mashup Score: 4
    SIR 2022 - 2 year(s) ago

    Future liver remnant (FLR) size and function is a critical limiting factor for treatment eligibility and postoperative prognosis when considering surgical hepatectomy. Preoperative portal vein embolization (PVE) has proven effective in modulating FLR and is now widely accepted as the gold standard. However, PVE is not always effective due to potentially inadequate FLR augmentation and tumor…

    Tweet Tweets with this article
    • Looking forward to great session this afternoon from 1pm to 2:30pm entitled "Preparing for Liver Surgery with "Alphabet Soup:" FLR Assessment, Techniques, Outcomes and Controversies" https://t.co/GnS2ayrnBN #SIR22BOS @SIRspecialists @SIR_ECS @SIRRFS https://t.co/9ricSDwrI8

  • Mashup Score: 2

    Purpose of review With the remarkable progress in cancer precision medicine, the demand for biopsy has been increasing, and the role of biopsy has been changing. In this review, we discuss the current state and recent advances in the role of image-guided percutaneous needle biopsy (PNB) in facilitating precision medicine. Recent findings Biopsies are useful not only in the diagnosis of cancer and…

    Tweet Tweets with this article
    • Hot off the press in Current Oncology Reports! Interesting article by Dr. Miyuki Sone & team from Tokyo's National Cancer Center Hospital on the critical role of image-guided percutaneous needle biopsy in the age of precision medicine. #irad #cancer https://t.co/EU12EMsIqH https://t.co/iSw7DpROP0